Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Zydus partners with ICMR to initiate Phase 2 clinical trials of Desidustat oral tablet for treating sickle cell disease

Zydus Lifesciences has formalized the Memorandum of Agreement (MoA) with Indian Council of Medical Research (ICMR) to initiate Phase 2 clinical trials of Desidustat in patients with Sickle Cell Disease.

By: business-standard.com

Oct 15 2024
0
0 Views

Zydus partners with ICMR to initiate Phase 2 clinical trials of Desidustat oral tablet for treating sickle cell disease

Zydus partners with ICMR to initiate Phase 2 clinical trials of Desidustat oral tablet for treating sickle cell disease

Related

Network 18 Media & Investments Ltd Spikes 3.48%

Oil & Natural Gas Corpn Ltd Falls 0.82%

Healthcare stocks edge higher

Information Technology shares gain

Utilties shares gain

Sunteck Realty spurts as pre-sales jumps 33% YoY in Q2

Zydus partners with ICMR to initiate Phase 2 clinical trials of Desidustat oral tablet for treating sickle cell disease

Cyient announces strategic partnership with Business Finland

Angel One spurts after Q2 PAT climbs 39% YoY to Rs 423 cr in FY25

TD Power Systems bags two export orders of Rs 142 cr

Network18, TV18 rally on RIL plans to close merger with Disney India in Q3

J Kumar Infra up 3% on Rs 298-cr work order from Pune Municipal Corporation

Network 18 Media & Investments Ltd Spikes 3.48%